Health ❯ Healthcare ❯ Cancer

Cancer Treatment

Immunotherapy Chemotherapy Clinical Trials Patient Support Patient Experience Palliative Care Patient Advocacy CAR T-cell Therapy Early Detection Cancer Survivorship

3 ARTICLES

2w ago

Daraxonrasib Doubles Survival in Phase 3 Trial for Advanced Pancreatic Cancer

If approved, the oral pan‑RAS pill would be the first broadly active KRAS inhibitor to meaningfully extend life for most patients with metastatic pancreatic cancer.

3 ARTICLES

last mo.

ctDNA Blood Test Guides Care as Targeted Radiotherapy Improves Control in Early Metastatic Cancer

4 ARTICLES

last mo.

King Charles Shares Candid Detail From Cancer Treatment During Hospital Visit

8 ARTICLES

last mo.

NHS England Rolls Out One-Minute Keytruda Jab for Cancer Care

11 ARTICLES

2mo ago

Personalized mRNA Vaccine Shows Durable Survival Signal in Early Pancreatic Cancer

5 ARTICLES

2mo ago

Exercise Beats Ibuprofen in Early Trial for Chemo Brain

6 ARTICLES

2mo ago

Metformin Triggers Exercise-Linked Signal in Prostate Cancer Patients

4 ARTICLES

2mo ago

Osaka Study Finds Therapy-Related Acute Myeloid Leukemia Nearly Tripled Since 1990

5 ARTICLES

3mo ago

At-Home Exercise Eases Chemo-Related Cognitive Problems in 2-Week Cycles, Phase III Trial Finds

4 ARTICLES

3mo ago

Nature Study Flags ATF4 as Driver of Metastasis in Older Lung Cancer

8 ARTICLES

4mo ago

New Data Shows Nearly All NHS Trusts Miss 62‑Day Cancer Treatment Target in 2025

3 ARTICLES

4mo ago

BioNTech’s Personalized mRNA Vaccine Shows Durable Immune Response in Triple-Negative Breast Cancer Phase 1

3 ARTICLES

4mo ago

Ultrasound-Activated Nanobubbles Break Tumor Barriers in Mouse Study

31 ARTICLES

4mo ago

UK Sets 10-Year Cancer Plan to Raise Survival to 75% and Hit Waiting-Time Targets by 2029

3 ARTICLES

4mo ago

San Francisco Leaders Press Blue Shield Over Retired Firefighter’s Cancer Coverage

28 ARTICLES

5mo ago

U.S. Cancer Survival Reaches 70% in New ACS Report

Cancer Treatment

Daraxonrasib Doubles Survival in Phase 3 Trial for Advanced Pancreatic Cancer

ctDNA Blood Test Guides Care as Targeted Radiotherapy Improves Control in Early Metastatic Cancer

King Charles Shares Candid Detail From Cancer Treatment During Hospital Visit

NHS England Rolls Out One-Minute Keytruda Jab for Cancer Care

Personalized mRNA Vaccine Shows Durable Survival Signal in Early Pancreatic Cancer

Exercise Beats Ibuprofen in Early Trial for Chemo Brain

Metformin Triggers Exercise-Linked Signal in Prostate Cancer Patients

Osaka Study Finds Therapy-Related Acute Myeloid Leukemia Nearly Tripled Since 1990

At-Home Exercise Eases Chemo-Related Cognitive Problems in 2-Week Cycles, Phase III Trial Finds

Nature Study Flags ATF4 as Driver of Metastasis in Older Lung Cancer

Never miss stories about

Cancer Treatment

New Data Shows Nearly All NHS Trusts Miss 62‑Day Cancer Treatment Target in 2025

BioNTech’s Personalized mRNA Vaccine Shows Durable Immune Response in Triple-Negative Breast Cancer Phase 1

Ultrasound-Activated Nanobubbles Break Tumor Barriers in Mouse Study

UK Sets 10-Year Cancer Plan to Raise Survival to 75% and Hit Waiting-Time Targets by 2029

Morning Immunotherapy Boosts Survival in Lung Cancer Trial

India Waives Customs Duty on 17 Cancer Drugs and 7 Rare-Disease Therapies

Delani Diekmeier’s Scans Hold Stable as Next IMAZA Round Set for Feb. 11

U.S. Cancer Survival Hits 70% as ACS Warns Progress Is at Risk

San Francisco Leaders Press Blue Shield Over Retired Firefighter’s Cancer Coverage

U.S. Cancer Survival Reaches 70% in New ACS Report

Never miss stories about

Cancer Treatment